Found: 15
Select item for more details and to access through your institution.
Cuprizone‐induced graded oligodendrocyte vulnerability is regulated by the transcription factor DNA damage‐inducible transcript 3.
- Published in:
- Glia, 2019, v. 67, n. 2, p. 263, doi. 10.1002/glia.23538
- By:
- Publication type:
- Article
Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.
- Published in:
- Glia, 2017, v. 65, n. 12, p. 1900, doi. 10.1002/glia.23202
- By:
- Publication type:
- Article
Mitochondrial Impairment in Oligodendroglial Cells Induces Cytokine Expression and Signaling.
- Published in:
- Journal of Molecular Neuroscience, 2019, v. 67, n. 2, p. 265, doi. 10.1007/s12031-018-1236-6
- By:
- Publication type:
- Article
Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions.
- Published in:
- Journal of Molecular Neuroscience, 2018, v. 66, n. 2, p. 229, doi. 10.1007/s12031-018-1159-2
- By:
- Publication type:
- Article
Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
- Published in:
- Journal of Molecular Neuroscience, 2017, v. 62, n. 2, p. 232, doi. 10.1007/s12031-017-0924-y
- By:
- Publication type:
- Article
Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.
- Published in:
- Journal of Molecular Neuroscience, 2017, v. 61, n. 4, p. 617, doi. 10.1007/s12031-017-0903-3
- By:
- Publication type:
- Article
Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model.
- Published in:
- Metabolic Brain Disease, 2020, v. 35, n. 2, p. 353, doi. 10.1007/s11011-019-00488-z
- By:
- Publication type:
- Article
Multiple sclerosis animal models: a clinical and histopathological perspective.
- Published in:
- Brain Pathology, 2017, v. 27, n. 2, p. 123, doi. 10.1111/bpa.12454
- By:
- Publication type:
- Article
Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post‐mortem multiple sclerosis brain tissue.
- Published in:
- Journal of Neurochemistry, 2018, v. 145, n. 6, p. 504, doi. 10.1111/jnc.14335
- By:
- Publication type:
- Article
Laquinimod Supports Remyelination in Non-Supportive Environments.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 11, p. 1363, doi. 10.3390/cells8111363
- By:
- Publication type:
- Article
Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 2, p. 94, doi. 10.3390/cells8020094
- By:
- Publication type:
- Article
Cover Image, Volume 70, Issue 11.
- Published in:
- Glia, 2022, v. 70, n. 11, p. C1, doi. 10.1002/glia.24276
- By:
- Publication type:
- Article
Lipocalin 2 attenuates oligodendrocyte loss and immune cell infiltration in mouse models for multiple sclerosis.
- Published in:
- Glia, 2022, v. 70, n. 11, p. 2188, doi. 10.1002/glia.24245
- By:
- Publication type:
- Article
G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
- Published in:
- Molecular Neurobiology, 2019, v. 56, n. 2, p. 1109, doi. 10.1007/s12035-018-1146-1
- By:
- Publication type:
- Article
Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 8, p. 6237, doi. 10.1007/s12035-017-0838-2
- By:
- Publication type:
- Article